Skip to main content

Peer Review reports

From: Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden

Original Submission
23 Apr 2018 Submitted Original manuscript
13 Jul 2018 Reviewed Reviewer Report - David Kong
17 Aug 2018 Reviewed Reviewer Report - Chin Fen Neoh
20 Aug 2018 Reviewed Reviewer Report - Maricela C. Valerio
25 Aug 2018 Reviewed Reviewer Report - Hongbo Yang
24 Oct 2018 Author responded Author comments - Lefteris Floros
Resubmission - Version 2
24 Oct 2018 Submitted Manuscript version 2
5 Nov 2018 Reviewed Reviewer Report - Chin Fen Neoh
20 Dec 2018 Author responded Author comments - Lefteris Floros
Resubmission - Version 3
20 Dec 2018 Submitted Manuscript version 3
4 Jan 2019 Author responded Author comments - Lefteris Floros
Resubmission - Version 4
4 Jan 2019 Submitted Manuscript version 4
Publishing
7 Jan 2019 Editorially accepted
11 Feb 2019 Article published 10.1186/s12879-019-3683-2

You can find further information about peer review here.

Back to article page